Free Trial
→ SpaceX eyes a 1.75 trillion valuation - here's what to know (From Brownstone Research) (Ad)tc pixel Free CLOV Stock Alerts

Clover Health Investments (CLOV) Competitors

Clover Health Investments logo
$3.73 -0.19 (-4.85%)
Closing price 06/2/2026 04:00 PM Eastern
Extended Trading
$3.72 -0.02 (-0.40%)
As of 09:28 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

CLOV vs. VOYA, JXN, KNSL, OSCR, and BNRE

Should you buy Clover Health Investments stock or one of its competitors? MarketBeat compares Clover Health Investments with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Clover Health Investments include Voya Financial (VOYA), Jackson Financial (JXN), Kinsale Capital Group (KNSL), Oscar Health (OSCR), and Brookfield Reinsurance (BNRE). These companies are all part of the "insurance" industry.

How does Clover Health Investments compare to Voya Financial?

Voya Financial (NYSE:VOYA) and Clover Health Investments (NASDAQ:CLOV) are both mid-cap insurance companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk and earnings.

96.1% of Voya Financial shares are held by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are held by institutional investors. 1.6% of Voya Financial shares are held by company insiders. Comparatively, 23.5% of Clover Health Investments shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Voya Financial currently has a consensus target price of $88.30, suggesting a potential upside of 6.99%. Clover Health Investments has a consensus target price of $2.90, suggesting a potential downside of 22.25%. Given Voya Financial's stronger consensus rating and higher possible upside, equities research analysts clearly believe Voya Financial is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Voya Financial
1 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.64
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Voya Financial has a net margin of 8.24% compared to Clover Health Investments' net margin of -2.58%. Voya Financial's return on equity of 13.84% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Voya Financial8.24% 13.84% 0.52%
Clover Health Investments -2.58%-16.52%-9.28%

In the previous week, Voya Financial had 2 more articles in the media than Clover Health Investments. MarketBeat recorded 10 mentions for Voya Financial and 8 mentions for Clover Health Investments. Clover Health Investments' average media sentiment score of 0.64 beat Voya Financial's score of 0.51 indicating that Clover Health Investments is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Voya Financial
2 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Clover Health Investments
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Voya Financial has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.54, suggesting that its stock price is 154% more volatile than the broader market.

Voya Financial has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Voya Financial, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Voya Financial$8.19B0.91$654M$6.6212.47
Clover Health Investments$1.92B1.02-$85.55M-$0.12N/A

Summary

Voya Financial beats Clover Health Investments on 12 of the 16 factors compared between the two stocks.

How does Clover Health Investments compare to Jackson Financial?

Clover Health Investments (NASDAQ:CLOV) and Jackson Financial (NYSE:JXN) are both mid-cap insurance companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

Clover Health Investments has a beta of 2.54, indicating that its stock price is 154% more volatile than the broader market. Comparatively, Jackson Financial has a beta of 1.32, indicating that its stock price is 32% more volatile than the broader market.

19.8% of Clover Health Investments shares are held by institutional investors. Comparatively, 90.0% of Jackson Financial shares are held by institutional investors. 23.5% of Clover Health Investments shares are held by company insiders. Comparatively, 1.4% of Jackson Financial shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Jackson Financial has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Jackson Financial, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clover Health Investments$1.92B1.02-$85.55M-$0.12N/A
Jackson Financial$6.68B1.11$27M-$6.11N/A

Clover Health Investments presently has a consensus price target of $2.90, indicating a potential downside of 22.25%. Jackson Financial has a consensus price target of $115.80, indicating a potential upside of 9.04%. Given Jackson Financial's stronger consensus rating and higher possible upside, analysts plainly believe Jackson Financial is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Jackson Financial
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.43

Jackson Financial has a net margin of 0.00% compared to Clover Health Investments' net margin of -2.58%. Jackson Financial's return on equity of 17.21% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Clover Health Investments-2.58% -16.52% -9.28%
Jackson Financial N/A 17.21%0.49%

In the previous week, Clover Health Investments had 7 more articles in the media than Jackson Financial. MarketBeat recorded 8 mentions for Clover Health Investments and 1 mentions for Jackson Financial. Jackson Financial's average media sentiment score of 1.25 beat Clover Health Investments' score of 0.64 indicating that Jackson Financial is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Clover Health Investments
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Jackson Financial
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Jackson Financial beats Clover Health Investments on 12 of the 16 factors compared between the two stocks.

How does Clover Health Investments compare to Kinsale Capital Group?

Clover Health Investments (NASDAQ:CLOV) and Kinsale Capital Group (NYSE:KNSL) are both mid-cap insurance companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

Clover Health Investments has a beta of 2.54, suggesting that its share price is 154% more volatile than the broader market. Comparatively, Kinsale Capital Group has a beta of 0.91, suggesting that its share price is 9% less volatile than the broader market.

Clover Health Investments currently has a consensus price target of $2.90, suggesting a potential downside of 22.25%. Kinsale Capital Group has a consensus price target of $390.18, suggesting a potential upside of 32.22%. Given Kinsale Capital Group's higher possible upside, analysts plainly believe Kinsale Capital Group is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Kinsale Capital Group
2 Sell rating(s)
8 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00

Kinsale Capital Group has lower revenue, but higher earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Kinsale Capital Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clover Health Investments$1.92B1.02-$85.55M-$0.12N/A
Kinsale Capital Group$1.87B3.63$503.61M$22.7212.99

19.8% of Clover Health Investments shares are owned by institutional investors. Comparatively, 85.4% of Kinsale Capital Group shares are owned by institutional investors. 23.5% of Clover Health Investments shares are owned by company insiders. Comparatively, 5.6% of Kinsale Capital Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Kinsale Capital Group had 1 more articles in the media than Clover Health Investments. MarketBeat recorded 9 mentions for Kinsale Capital Group and 8 mentions for Clover Health Investments. Kinsale Capital Group's average media sentiment score of 0.93 beat Clover Health Investments' score of 0.64 indicating that Kinsale Capital Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Clover Health Investments
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Kinsale Capital Group
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Kinsale Capital Group has a net margin of 27.48% compared to Clover Health Investments' net margin of -2.58%. Kinsale Capital Group's return on equity of 25.82% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Clover Health Investments-2.58% -16.52% -9.28%
Kinsale Capital Group 27.48%25.82%8.20%

Summary

Kinsale Capital Group beats Clover Health Investments on 12 of the 15 factors compared between the two stocks.

How does Clover Health Investments compare to Oscar Health?

Clover Health Investments (NASDAQ:CLOV) and Oscar Health (NYSE:OSCR) are both mid-cap insurance companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk.

19.8% of Clover Health Investments shares are owned by institutional investors. Comparatively, 75.7% of Oscar Health shares are owned by institutional investors. 23.5% of Clover Health Investments shares are owned by company insiders. Comparatively, 25.1% of Oscar Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Clover Health Investments currently has a consensus target price of $2.90, suggesting a potential downside of 22.25%. Oscar Health has a consensus target price of $19.22, suggesting a potential downside of 9.27%. Given Oscar Health's stronger consensus rating and higher possible upside, analysts clearly believe Oscar Health is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Oscar Health
2 Sell rating(s)
7 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.17

Clover Health Investments has higher earnings, but lower revenue than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Clover Health Investments, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clover Health Investments$1.92B1.02-$85.55M-$0.12N/A
Oscar Health$11.70B0.55-$443.15M-$0.59N/A

Clover Health Investments has a beta of 2.54, meaning that its share price is 154% more volatile than the broader market. Comparatively, Oscar Health has a beta of 2.37, meaning that its share price is 137% more volatile than the broader market.

In the previous week, Clover Health Investments had 4 more articles in the media than Oscar Health. MarketBeat recorded 8 mentions for Clover Health Investments and 4 mentions for Oscar Health. Oscar Health's average media sentiment score of 0.94 beat Clover Health Investments' score of 0.64 indicating that Oscar Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Clover Health Investments
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Oscar Health
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Oscar Health has a net margin of -0.30% compared to Clover Health Investments' net margin of -2.58%. Oscar Health's return on equity of -3.26% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Clover Health Investments-2.58% -16.52% -9.28%
Oscar Health -0.30%-3.26%-0.57%

Summary

Oscar Health beats Clover Health Investments on 11 of the 17 factors compared between the two stocks.

How does Clover Health Investments compare to Brookfield Reinsurance?

Clover Health Investments (NASDAQ:CLOV) and Brookfield Reinsurance (NYSE:BNRE) are both mid-cap insurance companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, profitability, valuation, media sentiment, dividends and risk.

Clover Health Investments has a beta of 2.54, meaning that its share price is 154% more volatile than the broader market. Comparatively, Brookfield Reinsurance has a beta of 1.53, meaning that its share price is 53% more volatile than the broader market.

Brookfield Reinsurance has higher revenue and earnings than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Brookfield Reinsurance, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clover Health Investments$1.92B1.02-$85.55M-$0.12N/A
Brookfield Reinsurance$9.35B0.70$796M$0.29156.31

Clover Health Investments presently has a consensus price target of $2.90, suggesting a potential downside of 22.25%. Given Clover Health Investments' stronger consensus rating and higher probable upside, equities analysts plainly believe Clover Health Investments is more favorable than Brookfield Reinsurance.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Brookfield Reinsurance
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Clover Health Investments had 8 more articles in the media than Brookfield Reinsurance. MarketBeat recorded 8 mentions for Clover Health Investments and 0 mentions for Brookfield Reinsurance. Clover Health Investments' average media sentiment score of 0.64 beat Brookfield Reinsurance's score of 0.00 indicating that Clover Health Investments is being referred to more favorably in the media.

Company Overall Sentiment
Clover Health Investments Positive
Brookfield Reinsurance Neutral

19.8% of Clover Health Investments shares are owned by institutional investors. Comparatively, 7.2% of Brookfield Reinsurance shares are owned by institutional investors. 23.5% of Clover Health Investments shares are owned by insiders. Comparatively, 1.0% of Brookfield Reinsurance shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Brookfield Reinsurance has a net margin of 0.10% compared to Clover Health Investments' net margin of -2.58%. Brookfield Reinsurance's return on equity of 0.14% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Clover Health Investments-2.58% -16.52% -9.28%
Brookfield Reinsurance 0.10%0.14%0.01%

Summary

Clover Health Investments beats Brookfield Reinsurance on 9 of the 16 factors compared between the two stocks.

Get Clover Health Investments News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLOV and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLOV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLOV vs. The Competition

Export
MetricClover Health InvestmentsMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$2.06B$1.62B$6.32B$12.58B
Dividend YieldN/AN/A2.69%5.45%
P/E Ratio-31.0878.2721.0424.56
Price / Sales1.0223.73561.99126.87
Price / CashN/A23.1542.3157.88
Price / Book6.324.829.836.75
Net Income-$85.55M-$54.76M$3.56B$337.19M
7 Day Performance3.90%1.33%-0.44%1.88%
1 Month Performance37.64%7.69%4.58%6.59%
1 Year Performance20.32%-1.41%27.58%35.52%

Clover Health Investments Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLOV
Clover Health Investments
1.1448 of 5 stars		$3.73
-4.8%		$2.90
-22.3%		+17.7%$2.06B$1.92BN/A680
VOYA
Voya Financial
4.8248 of 5 stars		$82.37
0.0%		$88.40
+7.3%		+24.9%$7.47B$8.19B12.4411,000
JXN
Jackson Financial
1.7461 of 5 stars		$107.12
+0.2%		$115.80
+8.1%		+28.7%$7.46B$6.68BN/A3,890
KNSL
Kinsale Capital Group
4.4064 of 5 stars		$310.59
+0.1%		$390.18
+25.6%		-37.5%$7.15B$1.87B13.67470
OSCR
Oscar Health
3.5989 of 5 stars		$22.67
+0.1%		$18.22
-19.6%		+48.5%$6.83B$11.70BN/A2,305

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:CLOV) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
June 12: $100 Turns Into $100,000?
The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla,...
Brownstone Research | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel